A Bunch of Attorneys General Have Put the American Academy of Pediatrics on Notice. What does it mean?
A Bunch of Attorneys General Have Put the American Academy of Pediatrics on Notice. What does it mean?
Has the AAP violated state consumer protection statutes with its statements on puberty blockers?
On September 24th, Idaho Attorney General Raúl R. Labrador and 20 other states sent a letter to the American Academy of Pediatrics (AAP) requesting information and informing the AAP that it has possibly violated numerous state consumer protection statutes with its promotion of an unproven medical treatment plan for minors struggling with gender dysphoria. Of particular concern to the AGs is the claim that “puberty blockers” are “reversible.”
This post on the Idaho Attorney General’s website, explains the reasoning behind the letter:
Most concerning, AAP claims that the use of puberty blockers on children is safe and reversible. This assertion is not grounded in evidence and therefore may run afoul of consumer protection laws in most states.
The letter requests detailed information from the AAP regarding its communications and practices related to youth gender dysphoria and substantiation of the Academy’s claims regarding the safety and reversibility of puberty blockers.
The letter sent to the AAP requests detailed disclosure from the AAP on its reasons and methodology in developing their gender-affirming care protocols in an effort to understand how the AAP came to recommend these treatments, why this protocol became standard practice across the country, and if the AAP has been knowingly deceiving American doctors, practitioners, patients, parents, and the general public with their guidelines.
Some of the requests in the letter include:
Explain the draft and review process for the 2018 AAP policy statement and subsequent reaffirmation, including any efforts to verify claims that puberty blockers are reversible when used to treat adolescents suffering with gender dysphoria.
Provide a copy of all communications you have had between January 1, 2020 to the present with WPATH regarding the SOC8, including any input into the drafting process.
Provide all AAP guidance and recommendations relating to physicians or medical personnel discussing gender dysphoria, suicidality, and similar conditions with minor patients, including scripts, training materials, and best clinical practices.
There is so much more, and we recommend you read the full letter here.
So what does this mean? We recommend you follow
on X for some ongoing commentary and analysis from a lawyer’s perspective. Starting with this thread:https://x.com/unyieldingbicyc/status/1838654593439314069
For additional context, here are some previous episodes of Gender: A Wider Lens that will shed some light on the particulars in the AGs’ letter. Please discuss your thoughts on all of this in the comments section below.
Fascinating. This will cause more of a stir than people imagine. Legal "discovery" process will be disasterous since the actual care for anxiety or delusion is anti-anxiety medication or talk therapy.
There are only 71 "gender" clinics in the US, all other care is via hospital and care geoups.
The Affordable Care Act under section 1557 mandating insurance providers _must_ cover gender-affirming treatments.
They will move "gender affirming" care to only anti-anxiety medications and talk therapy if they want to sustain malpractice group coverage as well as ACA qualification.
Pediatrics don't have a leg to stand on.
Several thinkers I know on the subject feel this is clearly a a wedge issue for unrelated attacks both on GLB groups, but it can potentially be sufficient to bankrupt Planned Parenthood which has become a major provider of "affirmation care" instead of reproductive services.
Each organization which became parasitized by Trans will have huge impacts over time - any women's righta and any Gay Rights, and political organizations. It's starting